Leaflet CICLOFOSFAMIDA SANDOZ 500mg powder for solution for injection / infusion

Indicated for: cancer

Route of administration: injectable / infusion

Substance: cyclophosphamide (alkylating antineoplastic agent)

ATC: L01AA01 (Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues)

Precautions:
Fertility warning
Fertility warning

This medicine may affect fertility.

Dose adjustment in hepatic impairment
Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Cytotoxic / special handling
Cytotoxic / special handling

Handle with special care.

Contraception required
Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding
Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hepatotoxicity
Hepatotoxicity

This medicine may affect the liver.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis
Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Severe skin reactions
Severe skin reactions

Stop taking the medicine and seek urgent medical help if a severe rash occurs.

Cyclophosphamide is a chemotherapy drug used to treat various types of cancer, including lymphomas, leukemias, and breast cancer. It belongs to the class of alkylating agents and works by destroying cancer cells and preventing them from dividing.

The medication is administered intravenously or orally, depending on the type and stage of cancer. It is often used in combination with other chemotherapy drugs to enhance treatment effectiveness.

Side effects may include nausea, vomiting, hair loss, fatigue, and an increased risk of infections. In rare cases, it may cause kidney or bladder toxicity. It is important to follow all medical recommendations to minimize risks.

Consult your doctor to discuss the benefits and risks of treatment with Cyclophosphamide. Close monitoring is essential during treatment to manage potential side effects.

General data about CICLOFOSFAMIDA SANDOZ 500mg

  • Substance: cyclophosphamide
  • Date of latest medicines list: 01-07-2015
  • Product code: W61323001
  • Concentration: 500mg
  • Pharmaceutical form: powder for solution for injection / infusion
  • Quantity: 1
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for cyclophosphamide

  • 1000mg
  • 1000mg/2ml
  • 1g
  • 2000mg
  • 2000mg/4ml
  • 200mg
  • 200mg/ml
  • 500mg
  • 500mg/ml
  • 50mg